NIH

KL2 Program Directors

The KL2 Program is co-directed by Diane Thiboutot, MD at Penn State College of Medicine campus in Hershey and Lorah D. Dorn, PhD, CPNP, at the University Park campus.

Lorah D. Dorn, PhD, CPNP
Dr. Dorn is a tenured professor in the College of Nursing and holds adjunct appointments in Human Development and Family Studies and the Department of Pediatrics at the College of Medicine. She completed her Ph.D. in Human Development and Family Studies at Penn State and a post doctoral fellowship at the National Institutes of Health. Her first faculty appointment was in the School of Nursing and the Department of Psychiatry at the University of Pittsburgh where she also sat on the IRB during that time. From 2003-2013, Dr. Dorn served as Director of Research in the Division of Adolescent Medicine at the Cincinnati Children’s Hospital and Medical Center at the University of Cincinnati. While in Cincinnati she mentored several BIRCWH scholars along with junior faculty and fellows in Adolescent Medicine including those on K awards. She was involved in the Clinical and Translational Science Institute and chaired the Scientific Advisory Committee, a group responsible for reviewing and monitoring all protocols utilizing the services of the Clinical Research Center. In 2013, Dr. Dorn came to the College of Nursing at Penn State where she continues her research and teaching missions. She continues to mentor junior faculty and has served on the College level Promotion and Tenure Committee. Dorn’s biobehavioral research interdisciplinary focusing on biological transitions as a period of vulnerability. Her longitudinal studies include puberty, reproductive and stress hormones and various physical (e.g., bone density) and mental health (depression, behavior problems) outcomes in adolescence. Dr. Dorn has a strong record of external funding (R01, R21, R03s) and collaborative research partnerships. Relevant to the KL2 mentorship, she also has served as a regular member on NIH study section (Behavioral Mechanisms  of Emotion Stress and Health; MESH), an ad hoc member on other study sections and she has been chair of the interdisciplinary research committees on two of her professional organizations. Her research career and extensive mentorship at various levels provides a strong basis for co-leading the KL2 program with Dr. Thiboutot.

Diane Thiboutot, M.D.
Dr. Thiboutot is a tenured professor in the Department of Dermatology at the College of Medicine, Associate Dean of Clinical and Translational Research Education and Training at Penn State, former co-director of Penn State’s M.D./Ph.D. program and former medical director for Penn State’s K30 Program. She has years of experience in administration of these programs. Dr. Thiboutot has been co-director of the Clinical and Translational Science Institute’s KL2 program since 2011 and now will serve as associate program director. Her research focuses on translational studies investigating the mechanisms by which retinoids regulate skin biology. Her laboratory has partnered with industry to test novel compounds that reduce skin lipid production. To date, three compounds initially tested in her laboratory are now in multi-center Phase 2 clinical trials for acne. Dr. Thiboutot manages an active clinical research unit in dermatology (over 100 trials) as well as serving as PI on an NIH U01 award to develop outcomes measures for acne clinical trials. As part of this project, she leads an international team with members in the United States, Canada and United Kingdom. Dr. Thiboutot is actively involved in mentoring KL2 scholars, M.D./Ph.D. students, graduate students, junior faculty in her department, as well as, other junior faculty applying for K awards. She co-directs Penn State’s K award workshop. Dr. Thiboutot’s research career was fostered by excellent mentorship in a collaborative environment and funding through Dermatology Foundation fellowships, a K08 award and subsequently R01 and U01 awards. Dr. Thiboutot has served on the Arthritis Connective Tissue and Skin study section of the NIH and continues to served on an ad hoc basis. She is committed to fostering the next generation of clinical and translational researchers.